The medical devices market in Russia reached a revenue of nearly *** billion Russian rubles in 2020, having more than doubled from the previous year. In 2021, the market size was expected to decrease slightly before increasing to around ***** billion Russian rubles in 2022.

In 2025, the Russia Medical Devices market is valued at approximately $ 10.8 billion, with a projected CAGR of 8.8% over the next five years. Additionally, by 2031, the market is expected to reach around $ 16.4 billion. The healthcare sector holds significant position in the overall market.

Medical devices for diagnostic visualization occupied the largest share of the medical devices market in Russia in 2021, at ********* of the total revenue. Technology for laboratory (in-vitro) diagnostics accounted for a slightly lower share.

Russia Medical Devices and Diagnostics Market valued at USD 8.5 Bn, driven by aging population, chronic diseases, and tech advancements, with growth in telemedicine and private healthcare.

USD 60.17 Million in 2024; projected USD 223.67 Million by 2033; CAGR 15.58%.

In the medical devices market in Russia in 2024, the other medical devices segment generated the highest revenue, reaching approximately ************ U.S. dollars. The cardiology devices segment ranked second with around ************** U.S. dollars, while diagnostic imaging devices followed with about ************** U.S. dollars.

USD 543.4 Million in 2024; projected USD 993.5 Million by 2033; CAGR 6.93%.

The number of users is forecast to experience significant growth in all segments in 2029. As part of the positive trend, the number of users reaches the maximum value for all three different segments at the end of the comparison period. Particularly noteworthy is the segment Digital Fitness & Well-Being, which is to have the highest value of **** million users in 2029. Find further statistics on other topics such as a comparison of the average revenue per user in Niger and a comparison of the average revenue per user in the United States.The Statista Market Insights cover a broad range of additional markets.

Russia Medical Products Market is expected to grow during 2025-2031

The Russia Disposables market is anticipated to grow with more than 7.58% CAGR from 2023 to 2028.

Between 2025 and 2029, the revenue of digital health in Russia is forecast to significantly increase in all segments. Particularly noteworthy is the segment Digital Treatment & Care, which has the highest value of over *** billion U.S. dollars. Find further statistics on other topics such as a comparison of the number of users in South Korea and a comparison of the average revenue per user in Benin.The Statista Market Insights cover a broad range of additional markets.

USD 8570.84 Million in 2024; projected USD 24203.98 Million by 2033; CAGR 12.22%.

As the population ages and healthcare spending increases, medical and dental instrument and supply manufacturers in Europe experience strong demand. An ageing population across European nations and rising chronic disease cases fuel demand for healthcare services. However, manufacturers also face challenges, including strict regulatory burdens and intense competition. Revenue is expected to hike at a compound annual rate of 0.9% to €135.8 billion over the five years through 2025, including a 2.5% hike in 2025. The profit margin is estimated at 16.2%. Favourable demographics support demand for medical and dental instruments. Strong healthcare sectors and significant funding across European nations benefit medical and dental equipment manufacturers. However, local manufacturers have to contend with competition from cheaper import alternatives, particularly from Asian countries, putting pressure on prices. Despite this, Europe’s renowned reputation for high-quality, advanced medical equipment supports exports. Stricter EU regulations, like the MDR and IVDR, have severely inflated compliance costs for manufacturers. Supply chain issues, heightened manufacturing costs, and the Russia-Ukraine conflict have posed challenges to European manufacturers since 2022, hampering production and weakening industry profitability. Revenue is forecast to expand at a compound annual rate of 4.9% to €172.8 billion over the five years through 2030. The ageing European population will create a steady demand for healthcare services—a big win for medical and dental equipment manufacturers. Technological advances, like 3D printing, will make it faster and cheaper to produce equipment while improving patient care. However, major hurdles for manufacturers include the strict regulations and upcoming bans on certain chemicals in Europe, alongside increasing competition from Asia. Efficiency gains through automation and digital processes, along with strong demand for healthcare services, will support manufacturers’ profitability.

Russia's market is projected to grow by more than 6% CAGR from 2024 to 2029, driven by the increasing demand for emergency medical services and the need for advanced emergency care

Telemedicine was the largest segment of the Russian medical technology (MedTech) market, with a revenue of nearly *** billion Russian rubles in 2022. It was followed by medical devices, whose market size reached *** billion Russian rubles in the same year.

The number of users in the 'Digital Fitness & Well-Being' segment of the digital health market in Russia was modeled to amount to ************* users in 2024. Following a continuous upward trend, the number of users has risen by ************* users since 2017. Between 2024 and 2029, the number of users will rise by ************ users, continuing its consistent upward trajectory.Further information about the methodology, more market segments, and metrics can be found on the dedicated Market Insights page on Digital Fitness & Well-Being.

The Russia Medical Gas and Equipment market will grow at more than 6.37% CAGR by 2030 driven by localized production and regional hospital expansion.

Russia Diabetes Drugs And Devices Market size was valued at USD 13.9 Billion in 2024 and is projected to reach USD 32.2 Billion by 2032, growing at a CAGR of 11.1% from 2026 to 2032.

Russia Diabetes Drugs and Devices Market: Definition/ Overview

Diabetes drugs and devices refer to pharmaceutical treatments and medical equipment designed to manage and regulate blood sugar levels in individuals with diabetes. These include insulin therapies, oral medications, continuous glucose monitoring systems, insulin pumps, and glucose test strips. Diabetes drugs, such as metformin and GLP-1 receptor agonists, help control blood sugar levels, while devices like insulin pens, pumps, and CGM systems enhance the precision and convenience of diabetes management. The future scope of diabetes drugs and devices is promising, with ongoing advancements in personalized medicine, artificial pancreas systems, and non-invasive monitoring technologies.

The Russian diabetes care devices market exhibits robust growth potential, projected to reach a market size of $1.34 billion in 2025, expanding at a compound annual growth rate (CAGR) of 4.53% from 2019 to 2033. This growth is fueled by several key factors. The rising prevalence of diabetes in Russia, driven by factors such as increasing urbanization, sedentary lifestyles, and poor dietary habits, is a primary driver. Furthermore, an aging population and improved healthcare infrastructure contribute to heightened demand for advanced diabetes management solutions, including continuous glucose monitors (CGMs), insulin pumps, and blood glucose meters. Government initiatives aimed at improving diabetes care access and affordability also positively impact market expansion. However, economic factors and the potential for price sensitivity among consumers may act as restraints. The market is segmented by device type (CGMs, insulin pumps, blood glucose meters, etc.), end-user (hospitals, clinics, home-use), and distribution channels (pharmacies, online retailers, etc.). Key players such as Roche, Sanofi, Novo Nordisk, and Medtronic are actively competing within this dynamic market, leveraging their technological advancements and strong distribution networks to capture market share. The increasing adoption of telemedicine and remote patient monitoring technologies also presents significant opportunities for growth, particularly in improving patient outcomes and reducing healthcare costs. Future market expansion will likely depend on sustained government support for diabetes care, continued technological innovation, and increased patient awareness regarding effective diabetes management techniques. The forecast period of 2025-2033 promises even greater market expansion, driven by continuous technological improvements. The introduction of new, more accurate, and user-friendly devices, combined with expanding access to affordable healthcare, will likely accelerate market growth. A deeper understanding of regional disparities in diabetes prevalence and access to care will be crucial for targeting specific segments and maximizing market penetration. Companies are investing in research and development to bring innovative devices to the market, further fueling market growth. Strategic partnerships and collaborations within the healthcare ecosystem will play a vital role in streamlining distribution channels and ensuring patient access to advanced diabetes care devices. Key drivers for this market are: Rising Prevalence of Cancer Worldwide, Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment. Potential restraints include: High Cost of Molecular Diagnostic Tests, Lack of Skilled Workforce and Stringent Regulatory Framework. Notable trends are: Continuous glucose monitoring segment is expected to witness a healthy growth rate over the forecast period.

Discover the booming Russian diabetes care devices market! This in-depth analysis reveals market size, growth projections (CAGR), key players (Abbott, Roche, Medtronic), and crucial market trends from 2019-2033, focusing on self-monitoring, continuous glucose monitoring, and insulin delivery devices. Learn about opportunities and challenges in this dynamic sector. Recent developments include: February 2023: Medtronic PLC announced one-year data from the ADAPT study, the first multi-national randomized controlled study comparing the MiniMed 780G advanced hybrid closed loop system (AHCL) performance against multiple daily injections of insulin with an intermittently scanned CGM. The study was done in adults (18 years of age and older) not meeting glycemic targets. At one-year, significant improvements were reproduced in this cross-over group and sustained in those that started on AHCL therapy at the start of the trial., April 2022: CamDiab and Ypsomed announced the partnership to develop and commercialize an integrated automated insulin delivery system to help lessen the burden of diabetes management for people with diabetes in European countries. The new integrated AID system is designed to connect Abbott's FreeStyle Libre 3 sensor, the world's smallest and most accurate continuous glucose monitoring sensor, to CamDiab's CamAPS FX mobile app. It connects with Ypsomed's mylife YpsoPump creating a smart, automated process to deliver insulin based on real-time glucose data.. Notable trends are: Continuous glucose monitoring segment is expected to witness a healthy growth rate over the forecast period.